Search Results for keywords:"Clinical Trials"

Found 3 results
Skip to main content

Search Results: keywords:"Clinical Trials"

  • Type:Rule
    Citation:89 FR 97558
    Reading Time:about 8 minutes

    The Department of Health and Human Services (HHS), via the National Institutes of Health (NIH), has amended a regulation regarding clinical trials. This change updates the web address in the regulation concerning where to find information about submitting trial data to ClinicalTrials.gov. The new rule removes the old URL https://prsinfo.clinicaltrials.gov and replaces it with https://clinicaltrials.gov or a future site, modernizing and centralizing information access. This amendment is technical and does not add new requirements for affected parties.

    Simple Explanation

    The government has decided to update the address you use to find information about clinical trials online. Now, you can go to ClinicalTrials.gov for what you need instead of the old website, making it all a bit easier and tidier.

  • Type:Notice
    Citation:90 FR 5893
    Reading Time:about 6 minutes

    The Food and Drug Administration (FDA) has released a draft guidance for companies developing drugs and biological products aimed at preventing and treating chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients. CIPN is a painful condition that can disrupt chemotherapy, affecting patients' survival by leading to treatment interruptions or dose reductions. The guidance offers recommendations for clinical trials, including the selection of trial participants and appropriate study endpoints. The public is encouraged to provide feedback on the draft by March 18, 2025, to help shape the final version.

    Simple Explanation

    The FDA made a draft guide to help companies make medicines for cancer patients to stop a painful problem called chemotherapy-induced peripheral neuropathy. They want people to share their thoughts about this guide by March 18, 2025.

  • Type:Notice
    Citation:86 FR 8210
    Reading Time:about a minute or two

    The National Cancer Institute is hosting a virtual meeting of the Clinical Trials and Translational Research Advisory Committee on March 17, 2021. The meeting will discuss strategic plans for the Institute's clinical and translational research programs. It is open to the public and can be accessed via the NIH webcasting site. For special accommodations or to submit comments, individuals can contact Sheila A. Prindiville at the details provided in the notice.

    Simple Explanation

    The National Cancer Institute is having an online meeting where they will talk about plans for their research about cancer. People can watch the meeting from their computers, and if anyone needs help to join or has questions, they can contact Sheila for more information.